HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zeeuw, E. J. L. Articles by Truyen, U. Search for Related Content PubMed PubMed Citation Articles by Zeeuw, E. J. L. Articles by Truyen, U. Agricola Articles by Zeeuw, E. J. L. Articles by Truyen, U.

Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts

¹ Institute for Animal Hygiene and Veterinary Public Health, Faculty of Veterinary Medicine, University of Leipzig, An den Tierkliniken 1, 04103 Leipzig, Germany
² Impfstoffwerke Dessau-Tornau GmbH, PF 400214, 06855 Rosslau, Germany

Correspondence
U. Truyen
truyen{at}vmf.uni-leipzig.de

The pathogenicity of two recent German field isolates of Porcine parvovirus (PPV-27a and PPV-143a) and two vaccine viruses [PPV-NADL-2 and PPV-IDT (MSV)], which are used for the production of inactivated vaccines, was investigated by inoculation of pregnant sows at day 40 of gestation. Post-infection sera of these sows as well as antisera prepared in rabbits by immunization with the four above-mentioned PPV isolates and with the virulent strain PPV-Challenge (Engl.) were tested for their homologous and heterologous neutralization activities. All antisera had high neutralization activity against the vaccine viruses, the PPV-Challenge (Engl.) virus and PPV-143a, but much lower activity against PPV-27a. These results suggest that PPV-27a represents a new antigenic variant or type of PPV and vaccines based on the established vaccine viruses may not be fully protective against this field isolate. PPV-27a has been characterized based on the amino acid sequences of the capsid protein as a member of a new and distinct PPV cluster (Zimmermann et al., 2006). Interestingly, the homologous neutralizing antibody titres of the sera of all three pigs and both rabbits inoculated or immunized with PPV-27a were 100- to 1000-fold lower than the heterologous titres against any of the other viruses. The low homologous neutralizing antibody titres suggest a possible, yet undefined, immune escape mechanism of this PPV isolate.

This article has been cited by other articles:

				A. Jozwik, J. Manteufel, H.-J. Selbitz, and U. Truyen Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain J. Gen. Virol., October 1, 2009; 90(10): 2437 - 2441. [Abstract] [Full Text] [PDF]

				N. Decaro, C. Desario, A. Miccolupo, M. Campolo, A. Parisi, V. Martella, F. Amorisco, M. S. Lucente, A. Lavazza, and C. Buonavoglia Genetic analysis of feline panleukopenia viruses from cats with gastroenteritis J. Gen. Virol., September 1, 2008; 89(9): 2290 - 2298. [Abstract] [Full Text] [PDF]

				A. Cavalli, V. Martella, C. Desario, M. Camero, A. L. Bellacicco, P. De Palo, N. Decaro, G. Elia, and C. Buonavoglia Evaluation of the Antigenic Relationships among Canine Parvovirus Type 2 Variants Clin. Vaccine Immunol., March 1, 2008; 15(3): 534 - 539. [Abstract] [Full Text] [PDF]

				L. A. Shackelton, K. Hoelzer, C. R. Parrish, and E. C. Holmes Comparative analysis reveals frequent recombination in the parvoviruses J. Gen. Virol., December 1, 2007; 88(12): 3294 - 3301. [Abstract] [Full Text] [PDF]